Responses
Regular and Young Investigator Award Abstracts
Biomarkers, Immune Monitoring and Novel Technologies
129 Modeling versatile three-dimensional patient-derived tumoroid (PDT) drug testing platforms by recapitulating tumor microenvironment oxygenation and immunocompetence
Compose a Response to This Article
Other responses
No responses have been published for this article.
